Nonuremic calciphylaxis in a patient with rheumatoid arthritis and osteoporosis treated with teriparatide.
Department of Dermatology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas. Electronic address: Arturo.Dominguez@UTSouthwestern.edu.
Arturo R
AR
Dominguez
University of Texas Southwestern Medical School, Dallas, Texas.
Shauna E
SE
Goldman
D001172:Arthritis, Rheumatoid / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002115:Calciphylaxis / Q000139:chemically induced* / Q000175:diagnosis; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004893:Erythema Nodosum / Q000139:chemically induced* / Q000175:diagnosis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage; D018570:Risk Assessment; D012720:Severity of Illness Index; D019379:Teriparatide / Q000008:administration & dosage / Q000009:adverse effects*; D014859:Warfarin / Q000008:administration & dosage
D050071:Bone Density Conservation Agents; D019379:Teriparatide; D014859:Warfarin; D011241:Prednisone